Britain Will Make Menopause Plans Mandatory for Large Employers From 2027

Companies in the United Kingdom with more than 250 staff will be legally required to publish a standalone menopause strategy from 2027, making Britain one of the first countries to turn the issue into a binding obligation for large employers.

The requirement sits at the centre of a wider international push that is steadily reshaping how workplaces handle symptoms that, according to one set of survey figures, more than 17 million French women alone say they have thought about.

France has moved on a parallel track. Its parliament published a report in 2025 containing 25 recommendations on menopause, and on 15 October 2026 Health Minister Stéphanie Rist convened the first Assises de la Ménopause in Paris. Data presented there found that one in three women has already run into difficulties at work because of menopause symptoms, while 83 per cent of women surveyed said menopause can affect working life.

Speaking at the same conference, Labour Minister Jean-Pierre Farandou said working conditions would be adapted. The planned measures include mobilising companies, making greater use of the occupational health check-up at mid-career, and giving occupational physicians better resources. The stated aim is to stop menopause from becoming a career obstacle.

A New ISO Standard, and a Canadian Voice on Implementation

Early in 2026 the International Organization for Standardization (ISO) published ISO 45010, a set of guidelines for employers supporting staff through menstruation and menopause. It is organised around four areas: the physical working environment, work design, company policies and organisational culture.

Brenda Baxter, chair of the Canadian Centre for Occupational Health and Safety and involved in drafting the standard, advised employers to review their workplace assistance programmes, insurance cover and health and safety policies.

Germany is watching closely, and its own figures sketch the scale of the problem. The Federal Anti-Discrimination Agency (Antidiskriminierungsstelle des Bundes) published a report titled "Gleichberechtigt in den Wechseljahren" — roughly, "Equal in the Menopause". Women aged 40 to 59 are among the country's most economically active groups, and nearly one in five working women is considering taking early retirement because of menopausal symptoms.

Pro Familia puts the number of people in Germany in the perimenopause at 9 to 11 million, 85 per cent of whom report similar symptoms. For Schleswig-Holstein, Achim Rody of the UKSH Lübeck cited estimates of 150,000 to 300,000 working women going through menopause. A German study from 2023 calculated the economic cost of menopausal symptoms at around 9.4 billion euros a year, alongside almost 40 million lost working days. For about half of women, the study found, the final period arrives around the age of 51 or 52.

Reluctance to Speak Up Carries a Price

Survey evidence points to a persistent silence. Environics polled working women aged 50 and over with perimenopause or menopause experience and found that 58 per cent said symptoms made it harder to perform effectively at work. Only 36 per cent felt comfortable raising their needs. Just 14 per cent believed their employer offered meaningful support, while 49 per cent said it did not. The same respondents were more likely than other women to turn to mental health support (17 per cent versus 8 per cent) and sleep aids (23 per cent versus 10 per cent).

Research by the Society for Women's Health Research found that 59 per cent of women are uncomfortable asking for workplace adjustments. An international study by the manufacturer Essity reported that only 20 per cent of women feel well informed about menopause, and just 27 per cent know what perimenopause means.

Some corporations have introduced voluntary add-ons. Salesforce offers global coaching programmes such as Cleo, up to 12 free counselling sessions a year through Lyra Health, and services from BetterUp, Midi Health, Carrot and Peppy.

Commercial interest is growing alongside the workplace debate. The Boston Consulting Group has put the financial potential of the menopause market at 350 billion US dollars, with investors and pharmaceutical companies committing billions to products and employer benefits. Specialists stress that awareness, flexible hours and understanding managers remain the measures that make the practical difference day to day.